Mutations in the LRRK2 gene represent the most common genetic cause of late onset Parkinson's disease. The physiological and pathological roles of LRRK2 are yet to be fully determined but evidence points towards LRRK2 mutations causing a gain in kinase function, impacting on neuronal maintenance, vesicular dynamics and neurotransmitter release. To explore the role of physiological levels of mutant LRRK2, we created knock-in (KI) mice harboring the most common LRRK2 mutation G2019S in their own genome. We have performed comprehensive dopaminergic, behavioral and neuropathological analyses in this model up to 24 months of age. We find elevated kinase activity in the brain of both heterozygous and homozygous mice. Although normal at 6 months, by 12 months of age, basal and pharmacologically induced extracellular release of dopamine is impaired in both heterozygous and homozygous mice, corroborating previous findings in transgenic models over-expressing mutant LRRK2. Via in vivo microdialysis measurement of basal and drug-evoked extracellular release of dopamine and its metabolites, our findings indicate that exocytotic release from the vesicular pool is impaired. Furthermore, profound mitochondrial abnormalities are evident in the striatum of older homozygous G2019S KI mice, which are consistent with mitochondrial fission arrest. We anticipate that this G2019S mouse line will be a useful pre-clinical model for further evaluation of early mechanistic events in LRRK2 pathogenesis and for second-hit approaches to model disease progression.
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Introduction
Mutations and genetic variability in the LRRK2 gene represent the most common genetic cause of Parkinson's disease (PD). The frequency of the pathogenic mutations is rare at around 2% overall (Di Fonzo et al., 2006; Farrer et al., 2007) , however the most common mutation G2019S is found in up to 40% of patients in certain ethnic populations (Kachergus et al., 2005; Ozelius et al., 2006; Ishihara et al., 2007) . In addition to pathogenic mutations, common genetic variability in LRRK2 is a risk factor for sporadic PD (Tan, 2006; Ross et al., 2008 Ross et al., , 2011 .
LRRK2 Parkinsonism has some unique features, including an agedependent penetrance (Healy et al., 2008; Hulihan et al., 2008) , with some aged carriers escaping disease (Kay et al., 2005) suggesting that disease manifestation is subject to other genetic or environmental modifiers, and potentially that the course of the disease may be altered by therapy. At the neuropathological level, LRRK2 Parkinsonism typically resembles idiopathic PD, exhibiting dopamine neuronal loss with synucleinopathy. Exceptions do exist in some kindreds, with patients that carry the same mutations having differential pathologies, including neuronal loss only and filamentous tau inclusions (Zimprich et al., 2004) . The presence of pathologies that overlap with other neurodegenerative diseases such as Alzheimer's disease and Progressive Supranuclear Palsy has led to speculation that LRRK2 dysfunction may be upstream of several important neuronal signaling cascades relevant to other neurodegenerative diseases, and as such, a LRRK2 based therapeutic may have wider applications than just LRRK2 PD.
The physiological and pathological roles of LRRK2 protein are not yet fully understood but it is generally accepted that it functions as a kinase, with an important role in neuronal maintenance, vesicular trafficking and neurotransmitter release in the brain. The overwhelming data from rodent models with near-physiologic levels of transgenic expression Neurobiology of Disease 78 (2015) 172-195 
